Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-FR Version v3-EN
Language French English
Date Updated 2020-06-10 2020-02-05
Drug Identification Number 02321149 02321149
Brand name MYLAN-NIFEDIPINE EXTENDED RELEASE MYLAN-NIFEDIPINE EXTENDED RELEASE
Common or Proper name NIFEDIPINE NIFEDIPINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients NIFEDIPINE NIFEDIPINE
Strength(s) 60MG 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-01-20 2020-01-20
Estimated end date 2020-07-07 2020-02-18
Actual end date 2020-06-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments